Effect of Surface Architecture on InVivo Ultrasound Contrast Persistence of Targeted Size-Selected Microbubbles

Cherry C. Chen, Shashank R. Sirsi, Shunichi Homma, Mark A. Borden

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Ultrasound molecular imaging is a powerful diagnostic modality using microbubbles coated with targeting ligands specific for endothelial biomarkers. The circulation persistence of ligand-bearing contrast agents is a key determinant in their contrast enhancement and targeting capability. Prior studies have shown that targeted microbubbles with ligands attached to the shell using the conventional exposed-ligand architecture (ELA) could trigger undesired ligand-induced complement activation and decreased circulation time. Microbubbles with the buried-ligand architecture (BLA), however, were found to inhibit complement activation and prolong circulation time. In the present study, we extended the stealth BLA microbubble design to size-selected (4 to 5-μm diameter) microbubbles targeted with cyclic RGD peptide using the postlabeling technique. Microbubble circulation persistence was measured in the healthy mouse kidney using a Visualsonics Vevo 770 scanner operating at 40 MHz in fundamental mode. The circulation persistence for targeted BLA microbubbles was significantly longer compared with their ELA counterparts and similar to no-ligand controls. Use of the BLA instead of the ELA increased the circulation half-life approximately two-fold. Analysis of the time-intensity and time-fluctuation curves with a two-compartment pharmacokinetic model showed a minimal degree of nonspecific vascular adhesion for any group. These results demonstrate the importance of surface architecture in the design of targeted microbubbles for ultrasound molecular imaging.

Original languageEnglish (US)
Pages (from-to)492-503
Number of pages12
JournalUltrasound in Medicine and Biology
Volume38
Issue number3
DOIs
StatePublished - Mar 1 2012

Fingerprint

Microbubbles
Ligands
ligands
Molecular Imaging
Complement Activation
complement
Ultrasonography
activation
Cyclic Peptides
biomarkers
kidneys
compartments
determinants
half life
Contrast Media
scanners
peptides
Blood Vessels
mice
Half-Life

Keywords

  • Clearance
  • Complement activation
  • Molecular imaging
  • Mononuclear phagocyte system
  • Mouse kidney
  • RGD peptide
  • Targeting

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Biophysics
  • Acoustics and Ultrasonics

Cite this

Effect of Surface Architecture on InVivo Ultrasound Contrast Persistence of Targeted Size-Selected Microbubbles. / Chen, Cherry C.; Sirsi, Shashank R.; Homma, Shunichi; Borden, Mark A.

In: Ultrasound in Medicine and Biology, Vol. 38, No. 3, 01.03.2012, p. 492-503.

Research output: Contribution to journalArticle

@article{9a8db3dc961041cdb0661c6fbba482b2,
title = "Effect of Surface Architecture on InVivo Ultrasound Contrast Persistence of Targeted Size-Selected Microbubbles",
abstract = "Ultrasound molecular imaging is a powerful diagnostic modality using microbubbles coated with targeting ligands specific for endothelial biomarkers. The circulation persistence of ligand-bearing contrast agents is a key determinant in their contrast enhancement and targeting capability. Prior studies have shown that targeted microbubbles with ligands attached to the shell using the conventional exposed-ligand architecture (ELA) could trigger undesired ligand-induced complement activation and decreased circulation time. Microbubbles with the buried-ligand architecture (BLA), however, were found to inhibit complement activation and prolong circulation time. In the present study, we extended the stealth BLA microbubble design to size-selected (4 to 5-μm diameter) microbubbles targeted with cyclic RGD peptide using the postlabeling technique. Microbubble circulation persistence was measured in the healthy mouse kidney using a Visualsonics Vevo 770 scanner operating at 40 MHz in fundamental mode. The circulation persistence for targeted BLA microbubbles was significantly longer compared with their ELA counterparts and similar to no-ligand controls. Use of the BLA instead of the ELA increased the circulation half-life approximately two-fold. Analysis of the time-intensity and time-fluctuation curves with a two-compartment pharmacokinetic model showed a minimal degree of nonspecific vascular adhesion for any group. These results demonstrate the importance of surface architecture in the design of targeted microbubbles for ultrasound molecular imaging.",
keywords = "Clearance, Complement activation, Molecular imaging, Mononuclear phagocyte system, Mouse kidney, RGD peptide, Targeting",
author = "Chen, {Cherry C.} and Sirsi, {Shashank R.} and Shunichi Homma and Borden, {Mark A.}",
year = "2012",
month = "3",
day = "1",
doi = "10.1016/j.ultrasmedbio.2011.12.007",
language = "English (US)",
volume = "38",
pages = "492--503",
journal = "Ultrasound in Medicine and Biology",
issn = "0301-5629",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Effect of Surface Architecture on InVivo Ultrasound Contrast Persistence of Targeted Size-Selected Microbubbles

AU - Chen, Cherry C.

AU - Sirsi, Shashank R.

AU - Homma, Shunichi

AU - Borden, Mark A.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Ultrasound molecular imaging is a powerful diagnostic modality using microbubbles coated with targeting ligands specific for endothelial biomarkers. The circulation persistence of ligand-bearing contrast agents is a key determinant in their contrast enhancement and targeting capability. Prior studies have shown that targeted microbubbles with ligands attached to the shell using the conventional exposed-ligand architecture (ELA) could trigger undesired ligand-induced complement activation and decreased circulation time. Microbubbles with the buried-ligand architecture (BLA), however, were found to inhibit complement activation and prolong circulation time. In the present study, we extended the stealth BLA microbubble design to size-selected (4 to 5-μm diameter) microbubbles targeted with cyclic RGD peptide using the postlabeling technique. Microbubble circulation persistence was measured in the healthy mouse kidney using a Visualsonics Vevo 770 scanner operating at 40 MHz in fundamental mode. The circulation persistence for targeted BLA microbubbles was significantly longer compared with their ELA counterparts and similar to no-ligand controls. Use of the BLA instead of the ELA increased the circulation half-life approximately two-fold. Analysis of the time-intensity and time-fluctuation curves with a two-compartment pharmacokinetic model showed a minimal degree of nonspecific vascular adhesion for any group. These results demonstrate the importance of surface architecture in the design of targeted microbubbles for ultrasound molecular imaging.

AB - Ultrasound molecular imaging is a powerful diagnostic modality using microbubbles coated with targeting ligands specific for endothelial biomarkers. The circulation persistence of ligand-bearing contrast agents is a key determinant in their contrast enhancement and targeting capability. Prior studies have shown that targeted microbubbles with ligands attached to the shell using the conventional exposed-ligand architecture (ELA) could trigger undesired ligand-induced complement activation and decreased circulation time. Microbubbles with the buried-ligand architecture (BLA), however, were found to inhibit complement activation and prolong circulation time. In the present study, we extended the stealth BLA microbubble design to size-selected (4 to 5-μm diameter) microbubbles targeted with cyclic RGD peptide using the postlabeling technique. Microbubble circulation persistence was measured in the healthy mouse kidney using a Visualsonics Vevo 770 scanner operating at 40 MHz in fundamental mode. The circulation persistence for targeted BLA microbubbles was significantly longer compared with their ELA counterparts and similar to no-ligand controls. Use of the BLA instead of the ELA increased the circulation half-life approximately two-fold. Analysis of the time-intensity and time-fluctuation curves with a two-compartment pharmacokinetic model showed a minimal degree of nonspecific vascular adhesion for any group. These results demonstrate the importance of surface architecture in the design of targeted microbubbles for ultrasound molecular imaging.

KW - Clearance

KW - Complement activation

KW - Molecular imaging

KW - Mononuclear phagocyte system

KW - Mouse kidney

KW - RGD peptide

KW - Targeting

UR - http://www.scopus.com/inward/record.url?scp=84863083413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863083413&partnerID=8YFLogxK

U2 - 10.1016/j.ultrasmedbio.2011.12.007

DO - 10.1016/j.ultrasmedbio.2011.12.007

M3 - Article

VL - 38

SP - 492

EP - 503

JO - Ultrasound in Medicine and Biology

JF - Ultrasound in Medicine and Biology

SN - 0301-5629

IS - 3

ER -